IDEXX Laboratories, Inc. (IDXX) updated its 2025 EPS outlook range to $12.81 -$13.01, incorporating a $0.33 increase at midpoint from prior guidance, reflecting$0.22 benefit from operational performance, $0.04 benefit from lower effective tax rate, net of impacts related to recent U.S. tax law changes, and approximately$0.07 combined benefit from updated estimates for interest expense, average shares outstanding, and foreign exchange impacts. The updated EPS growth outlook is 20% - 22% as reported and 1 ...